Completed NA NCT00066482

Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors

Pilot Study of Cisplatin, Etoposide, Bleomycin and Escalating Dose Cyclophosphamide Therapy for Children With High Risk Malignant Germ Cell Tumors

Sponsor: Children's Oncology Group

Conditions Childhood Germ Cell Tumor Extragonadal Germ Cell Tumor

Interventions MESNA bleomycin sulfate cisplatin conventional surgery cyclophosphamide etoposide filgrastim

Updated 6 times since 2017 Last updated: Oct 15, 2013 Started: Jul 31, 2004 Primary completion: Apr 30, 2007

Listed as NCT00066482, this NA trial focuses on Childhood Germ Cell Tumor and Extragonadal Germ Cell Tumor and remains completed. Sponsored by Children's Oncology Group, it has been updated 6 times since 2004, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jul 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Children's Oncology Group
National Cancer Institute (NCI)

Data source: Children's Oncology Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Akron, United States , Amarillo, United States , Ann Arbor, United States , Atlanta, United States , Austin, United States , Baltimore, United States , Bangor, United States , Birmingham, United States , Boston, United States , Charleston, United States and 76 more locations